Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Testosterone improves mood and thinking skills; finasteride has no effect.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Dying cells can help with faster healing and new hair growth by releasing a growth-promoting molecule.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Finasteride cream helps hair growth with less side effects.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Anabolic steroid users may face higher risk of severe COVID-19.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Substance from human umbilical cord blood cells promotes hair growth.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Mice with autoimmune hair loss showed signs of heart problems.

Finasteride exposure harms tadpole reproduction and hormone balance.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.